Effect of cilostazol on carotid intima-media thickness

VernacularTitle:西洛他唑对颈动脉内膜中层厚度影响的荟萃分析
Author: Jianyong LI ¹ ; Jiahai CHEN ; Jianmei XIONG ; Liuqing SUN ; Xiangyu CAO ; Fang CUI
Author Information

1. 解放军总医院海南分院神经内科
Keywords: atherosclerosis; carotid stenosis; platelet aggregation inhibitors; aspirin
From: Chinese Journal of Geriatric Heart Brain and Vessel Diseases 2018;20(6):618-622
CountryChina
Language:Chinese
Abstract: Objective To systematically assess whether cilostazol can delay the progression or decrease the carotid intima-media thickness (clMT).Methods Papers on the effect of cilostazol on cIMT in randomized controlled trials and cohort studies were retrieved from a number of foreign and domestic databases.The data were analyzed by Review Manager 5.3.Results Six randomized controlled trials and two cohort studies were included in this study.A total of 1107 patients were divided into cilostazol therapy group (n=533) and control group (n=574).Meta-analysis showed that cilostazol therapy for 6 months,12 months,≥24 months could reduce the maximum cIMT with a mean difference of-0.04 mm (95％CI:-0.05--0.03,P=0.000),a mean difference of -0.04 mm (95％CI:-0.05--0.03,P=0.000) and a mean difference of-0.08 mm (95％CI:-0.11-0.05,P =0.000) respectively.Conclusion Cilostazol therapy for 6 months,12 months,24 months or more than 24 months can reduce the maximum cIMT,which is needed to be confirmed by studies with a large sample of clinical data.